File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Deep Learning–Based Automated Imaging Classification of ADPKD

TitleDeep Learning–Based Automated Imaging Classification of ADPKD
Authors
Keywordsatypical cyst
deep learning
explainable artificial intelligence
polycystic kidney disease
risk factors
total kidney volume
Issue Date1-Jun-2024
PublisherElsevier
Citation
Kidney International Reports, 2024, v. 9, n. 6, p. 1802-1809 How to Cite?
AbstractIntroduction: The Mayo imaging classification model (MICM) requires a prestep qualitative assessment to determine whether a patient is in class 1 (typical) or class 2 (atypical), where patients assigned to class 2 are excluded from the MICM application. Methods: We developed a deep learning–based method to automatically classify class 1 and 2 from magnetic resonance (MR) images and provide classification confidence utilizing abdominal T2-weighted MR images from 486 subjects, where transfer learning was applied. In addition, the explainable artificial intelligence (XAI) method was illustrated to enhance the explainability of the automated classification results. For performance evaluations, confusion matrices were generated, and receiver operating characteristic curves were drawn to measure the area under the curve. Results: The proposed method showed excellent performance for the classification of class 1 (97.7%) and 2 (100%), where the combined test accuracy was 98.01%. The precision and recall for predicting class 1 were 1.00 and 0.98, respectively, with F1-score of 0.99; whereas those for predicting class 2 were 0.87 and 1.00, respectively, with F1-score of 0.93. The weighted averages of precision and recall were 0.98 and 0.98, respectively, showing the classification confidence scores whereas the XAI method well-highlighted contributing regions for the classification. Conclusion: The proposed automated method can classify class 1 and 2 cases as accurately as the level of a human expert. This method may be a useful tool to facilitate clinical trials investigating different types of kidney morphology and for clinical management of patients with autosomal dominant polycystic kidney disease (ADPKD).
Persistent Identifierhttp://hdl.handle.net/10722/365921

 

DC FieldValueLanguage
dc.contributor.authorSteinman, Theodore-
dc.contributor.authorWei, Jesse-
dc.contributor.authorCzarnecki, Peter-
dc.contributor.authorPedrosa, Ivan-
dc.contributor.authorBraun, William-
dc.contributor.authorNurko, Saul-
dc.contributor.authorRemer, Erick-
dc.contributor.authorChapman, Arlene-
dc.contributor.authorMartin, Diego-
dc.contributor.authorRahbari-Oskoui, Frederic-
dc.contributor.authorMittal, Pardeep-
dc.contributor.authorTorres, Vicente-
dc.contributor.authorHogan, Marie C.-
dc.contributor.authorEl-Zoghby, Ziad-
dc.contributor.authorHarris, Peter-
dc.contributor.authorGlockner, James-
dc.contributor.authorKing, Bernard-
dc.contributor.authorPerrone, Ronald-
dc.contributor.authorHalin, Neil-
dc.contributor.authorMiskulin, Dana-
dc.contributor.authorSchrier, Robert-
dc.contributor.authorBrosnahan, Godela-
dc.contributor.authorGitomer, Berenice-
dc.contributor.authorKelleher, Cass-
dc.contributor.authorMasoumi, Amirali-
dc.contributor.authorPatel, Nayana-
dc.contributor.authorWinklhofer, Franz-
dc.contributor.authorGrantham, Jared-
dc.contributor.authorYu, Alan-
dc.contributor.authorWang, Connie-
dc.contributor.authorWetzel, Louis-
dc.contributor.authorMoore, Charity G.-
dc.contributor.authorBost, James E.-
dc.contributor.authorBae, Kyongtae-
dc.contributor.authorAbebe, Kaleab Z.-
dc.contributor.authorMiller, J. Philip-
dc.contributor.authorThompson, Paul A.-
dc.contributor.authorBriggs, Josephine-
dc.contributor.authorFlessner, Michael-
dc.contributor.authorMeyers, Catherine M.-
dc.contributor.authorStar, Robert-
dc.contributor.authorShayman, James-
dc.contributor.authorHenrich, William-
dc.contributor.authorGreene, Tom-
dc.contributor.authorLeonard, Mary-
dc.contributor.authorMcCullough, Peter-
dc.contributor.authorMoe, Sharon-
dc.contributor.authorRocco, Michael-
dc.contributor.authorWendler, David-
dc.date.accessioned2025-11-12T00:36:33Z-
dc.date.available2025-11-12T00:36:33Z-
dc.date.issued2024-06-01-
dc.identifier.citationKidney International Reports, 2024, v. 9, n. 6, p. 1802-1809-
dc.identifier.urihttp://hdl.handle.net/10722/365921-
dc.description.abstractIntroduction: The Mayo imaging classification model (MICM) requires a prestep qualitative assessment to determine whether a patient is in class 1 (typical) or class 2 (atypical), where patients assigned to class 2 are excluded from the MICM application. Methods: We developed a deep learning–based method to automatically classify class 1 and 2 from magnetic resonance (MR) images and provide classification confidence utilizing abdominal T2-weighted MR images from 486 subjects, where transfer learning was applied. In addition, the explainable artificial intelligence (XAI) method was illustrated to enhance the explainability of the automated classification results. For performance evaluations, confusion matrices were generated, and receiver operating characteristic curves were drawn to measure the area under the curve. Results: The proposed method showed excellent performance for the classification of class 1 (97.7%) and 2 (100%), where the combined test accuracy was 98.01%. The precision and recall for predicting class 1 were 1.00 and 0.98, respectively, with F1-score of 0.99; whereas those for predicting class 2 were 0.87 and 1.00, respectively, with F1-score of 0.93. The weighted averages of precision and recall were 0.98 and 0.98, respectively, showing the classification confidence scores whereas the XAI method well-highlighted contributing regions for the classification. Conclusion: The proposed automated method can classify class 1 and 2 cases as accurately as the level of a human expert. This method may be a useful tool to facilitate clinical trials investigating different types of kidney morphology and for clinical management of patients with autosomal dominant polycystic kidney disease (ADPKD).-
dc.languageeng-
dc.publisherElsevier-
dc.relation.ispartofKidney International Reports-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectatypical cyst-
dc.subjectdeep learning-
dc.subjectexplainable artificial intelligence-
dc.subjectpolycystic kidney disease-
dc.subjectrisk factors-
dc.subjecttotal kidney volume-
dc.titleDeep Learning–Based Automated Imaging Classification of ADPKD-
dc.typeArticle-
dc.identifier.doi10.1016/j.ekir.2024.04.002-
dc.identifier.scopuseid_2-s2.0-85191490565-
dc.identifier.volume9-
dc.identifier.issue6-
dc.identifier.spage1802-
dc.identifier.epage1809-
dc.identifier.eissn2468-0249-
dc.identifier.issnl2468-0249-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats